Alexion Pharmaceuticals acquires Synageva BioPharma
23 June 2015 | By Victoria White
Alexion Pharmaceuticals has successfully completed its acquisition of Synageva BioPharma, strengthening Alexion's position in devastating and rare diseases...
List view / Grid view
News
Yusen expands collaborative pharma network servicing final mile distribution throughout Europe
The expanded service manages in-market supply to end users – hospitals, pharmacies, doctors, dentists, wholesalers, vaccination centres in 8 countries initially: Austria, Denmark, France, Italy, Spain, UK, Germany, Belgium, and Poland expected to follow later in the year.
New STI figures released by Public Health England
23 June 2015 | By Victoria White
Latest figures published by Public Health England (PHE) show there were 439,243 sexually transmitted infections (STIs) reported in England in 2014...
Roche announces further data from study of ACE910 in patients with severe haemophilia A
23 June 2015 | By Victoria White
Roche has announced new data from the first study of the novel humanised bispecific antibody ACE910 (RG6013) in people with severe haemophilia A...
Prescription-only vitamin D formulation launched in the UK
23 June 2015 | By Victoria White
Internis Pharmaceuticals has launched a new MHRA-licensed and approved vitamin D (colecalciferol) formulation in the UK - Fultium-D3 Drops...
Enrolment stops for Phase II TKM-Ebola-Guinea trial
23 June 2015 | By Victoria White
Tekmira has announced that the Phase II clinical trial of TKM-Ebola-Guinea has reached a predefined statistical endpoint and enrollment has been closed.
NICE publishes updated guidance to help GPs and patients recognise the signs of cancer
23 June 2015 | By Victoria White
NICE has updated and redesigned its guideline to support GPs and other primary care professionals to recognise the signs and symptoms of cancer...
Celsis Innovations meet the needs of growing manufacturing companies
22 June 2015 | By Celsis International
Celsis Advance II™ system helps Home, Beauty and Pharmaceutical product manufacturers enhance quality assurance while reducing manufacturing cycle times and inventory requirements...
First patient study data show that idarucizumab reverses dabigatran within minutes
22 June 2015 | By Victoria White
Results from an interim analysis of a Phase III study demonstrate that idarucizumab immediately reversed the anticoagulant effect of dabigatran...
Results of Phase 3 study of andexanet alfa presented at ISTH 2015
22 June 2015 | By Victoria White
Full results from the second part of a Phase 3 trial evaluating the safety and efficacy of andexanet alfa as a reversal agent of Eliquis have been announced...
Pfizer to acquire GSK meningitis vaccines
22 June 2015 | By Victoria White
Pfizer has entered into an agreement with GlaxoSmithKline to acquire its quadrivalent meningitis ACWY vaccines, Nimenrix and Mencevax, for $130 million...
New analysis from Phase 3 trial of Adcetris in Hodgkin’s lymphoma patients presented at ICML 2015
22 June 2015 | By Victoria White
Results from a new sub-analysis of the Phase 3 Aethera clinical trial of Adcetris were presented at the 13th International Conference on Malignant Lymphoma...
Epizyme releases additional data from Phase 1 study of tazemetostat in non-Hodgkin’s lymphoma
22 June 2015 | By Victoria White
Epizyme has reported results from the ongoing Phase 1 trial of tazemetostat in patients with advanced B-cell non-Hodgkin's lymphoma and solid tumours...
EC approves Opdivo for the treatment of advanced melanoma patients
22 June 2015 | By Victoria White
The European Commission has approved Bristol-Myers Squibb’s Opdivo, a PD-1 immune checkpoint inhibitor, for the treatment of advanced melanoma in adults...
CPhI China opens as country invests in R&D
22 June 2015 | By
CPhI China, hosted by UBM EMEA and CCCMHPIE, returns to the Shanghai New International Exhibition Centre, SNIEC, China from 24 to 26 June 2015...
